Journal of Occupational
Health and Epidemiology
Rafsanjan university Of medical sciences
Volume 13, Issue 4 (Autumn 2024)
J Occup Health Epidemiol 2024, 13(4): 225-232 |
Back to browse issues page
Ethics code: IR.SUMS.REC.1399.772
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Azarbakhsh H, Jafari F, Jaafari Z, Dehghani S P, Shoaahaghighi P, Mirahmadizadeh A. The Trend of Years of Life Lost Caused by 4 Main Non-Communicable Diseases in Fars Province in the Age Group of 30-70 Years. Joinpoint Regression Analysis. J Occup Health Epidemiol 2024; 13 (4) :225-232
URL: http://johe.rums.ac.ir/article-1-896-en.html
URL: http://johe.rums.ac.ir/article-1-896-en.html
Related article in
Google Scholar
Google Scholar
Similar articles
Habibollah Azarbakhsh1 
, Fatemeh Jafari2 , Zahra Jaafari2 , Seyed Parsa Dehghani3 , Pegah Shoaahaghighi4 , Alireza Mirahmadizadeh *5
, Fatemeh Jafari2 , Zahra Jaafari2 , Seyed Parsa Dehghani3 , Pegah Shoaahaghighi4 , Alireza Mirahmadizadeh *5
1- Ph.D. in Epidemiology, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
2- Ph.D. Student in Epidemiology, Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
3- Medical Doctor, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
4- B.Sc. in Medical Records, Health Vice-chancellor, Shiraz University of Medical Sciences, Shiraz, Iran
5- Associate Prof., Non-Communicable Research Center, Shiraz University of Medical Sciences, Shiraz, Iran ,mirahmadia@sums.ac.ir
2- Ph.D. Student in Epidemiology, Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
3- Medical Doctor, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
4- B.Sc. in Medical Records, Health Vice-chancellor, Shiraz University of Medical Sciences, Shiraz, Iran
5- Associate Prof., Non-Communicable Research Center, Shiraz University of Medical Sciences, Shiraz, Iran ,
Article history
Received: 2024/05/31
Accepted: 2024/10/10
ePublished: 2025/03/12
Accepted: 2024/10/10
ePublished: 2025/03/12
Subject:
Epidemiology
Abstract: (287 Views)
Background: This study aimed to investigate the trend of YLL created by four Non-communicable diseases (NCDs) in Fars province.
Materials and Methods: Data on the total number of NCD fatalities in southern Iran from 2004 to 2019 were gathered for this research from the population-based Electronic Death Registry System (EDRS). The JoinPoint Regression method was used to analyze the trends in the crude and age-standardized mortality rate and YLL rate.
Results: During the study period, 54,825 deaths occurred in terms of four NCDs in 30-70 years Fars in the province. The total YLL due to premature death during the sixteen-year study period was 558,316 in males and 401,595 in females. The largest number of YLL was caused by cardiovascular diseases 599,189 (62.7%). The sixteen-year trend of years of YLL owing to CVD was declining for both men and women, according to the joinpoint regression analysis. However, there was a constant tendency for females and a rising trend for men with cancer. Additionally, the YLL rate for diabetes in both boys and females showed steady trends. Furthermore, the trend of YLL rate due to chronic respiratory disease was increasing for males but had a stable trend for females.
Conclusions: The result of this study indicates that the YLL rate because of cardiovascular diseases has been declining. The YLL rates for diabetes, cancers, and chronic respiratory diseases have either increased or remained stable. These results carry important implications for public health policies and educational initiatives aimed at enhancing the prevention, early detection, and treatment of these diseases.
Materials and Methods: Data on the total number of NCD fatalities in southern Iran from 2004 to 2019 were gathered for this research from the population-based Electronic Death Registry System (EDRS). The JoinPoint Regression method was used to analyze the trends in the crude and age-standardized mortality rate and YLL rate.
Results: During the study period, 54,825 deaths occurred in terms of four NCDs in 30-70 years Fars in the province. The total YLL due to premature death during the sixteen-year study period was 558,316 in males and 401,595 in females. The largest number of YLL was caused by cardiovascular diseases 599,189 (62.7%). The sixteen-year trend of years of YLL owing to CVD was declining for both men and women, according to the joinpoint regression analysis. However, there was a constant tendency for females and a rising trend for men with cancer. Additionally, the YLL rate for diabetes in both boys and females showed steady trends. Furthermore, the trend of YLL rate due to chronic respiratory disease was increasing for males but had a stable trend for females.
Conclusions: The result of this study indicates that the YLL rate because of cardiovascular diseases has been declining. The YLL rates for diabetes, cancers, and chronic respiratory diseases have either increased or remained stable. These results carry important implications for public health policies and educational initiatives aimed at enhancing the prevention, early detection, and treatment of these diseases.
Keywords: Years of Life Lost [MeSH], Mortality Rate [MeSH], Regression [MeSH], Noncommunicable Diseases [MeSH], Iran [MeSH]
References
1. NCD Countdown 2030: worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4. Lancet (London, England). 2018;392(10152):1072-88. [DOI] [PMID]
2. World Health Organization. Non communicable diseases, Key facts: A review of the Field. Geneva, Switzerland: World Health Organization; 2022.
3. Mendis S. Global status report on noncommunicable diseases 2014. Geneva, Switzerland: World health organization; 2014.
4. World Health Organization. Global status report on noncommunicable diseases 2010. Geneva, Switzerland: World health organization; 2014.
5. World Health Organization. Assessing national capacity for the prevention and control of noncommunicable diseases: Report of the 2015 Global Survey. Geneva, Switzerland: World health organization; 2016. [URL]
6. World Health Organization. Global action plan for the prevention and control of noncommunicable diseases 2013-2020. Geneva, Switzerland: World health organization; 2013. [URL]
7. Peto R, Lopez AD, Norheim OF. Halving premature death. Science; 2014:345(6202):1272. [DOI] [PMID]
8. United Nations. Sustainable Development Goals: 17 Goals to Transform our World. New York, United States: United Nations; 2023.
9. World Health Organization. Life expectancy and Healthy life expectancy, Data by country. Geneva, Switzerland: World health organization; 2020. [URL]
10. World Health Organization. Noncommunicable diseases country profiles 2018. Geneva, Switzerland: World health organization; 2018 [URL]
11. GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1151-210. [DOI] [PMID] [PMCID]
12. Rabbani B, Khosravi A, Azimi M, Tabrizi JS, Atefi A, Ataey A, et al. Provincial Differential in Premature Deaths Due to the Non-communicable Diseases in Iran, 2016-2019. Iran J Epidemiol. 2023;18(4):292-304. [URL]
13. Mirahmadizadeh A, Vali M, Hassanzadeh J, Dehghani SP, Razeghi A, Azarbakhsh H. Mortality Rate and Years of Life Lost due to Hypertension in the South of Iran between 2004 and 2019: A Population-Based Study. Int J Hypertens. 2022;2022:7759699. [DOI] [PMID] [PMCID]
14. Azarbakhsh H, Sharifi MH, Hassanzadeh J, Dewey RS, Janfada M, Mirahmadizadeh A. Diabetes in southern Iran: a 16-year follow-up of mortality and years of life lost. Int J Diabetes Dev Ctries. 2023;43:574-80. [DOI]
15. Wakasugi M, Kazama JJ, Narita I. Premature mortality due to nephrotic syndrome and the trend in nephrotic syndrome mortality in Japan, 1995-2014. Clin Exp Nephrol. 2018;22(1):55-60. [DOI] [PMID]
16. Doblhammer G, Gumà J. A demographic perspective on gender, family and health in Europe. Berlin, Germany: Springer Nature; 2018. [DOI]
17. Wingard DL. The sex differential in morbidity, mortality, and lifestyle. Annu Rev Public Health. 1984;5:433-58. [DOI] [PMID]
18. Askari-Nodoushan A, Sasanipour M, Koosheshi M, Khosravi A. Patterns of sex differences in mortality in Iran, 2006-2015. Woman Dev Polit. 2018;16(3):415-38. [DOI]
19. Mendis S, Davis S, Norrving B. Organizational update: the world health organization global status report on noncommunicable diseases 2014; one more landmark step in the combat against stroke and vascular disease. Stroke. 2015;46(5):e121-2. [DOI] [PMID]
20. Prabhakaran D, Anand S, Watkins D, Gaziano T, Wu Y, Mbanya JC, et al. Cardiovascular, respiratory, and related disorders: key messages from Disease Control Priorities, 3rd edition. Lancet. 2018;391(10126):1224-36. [DOI] [PMID] [PMCID]
21. Gao Y, Su J, Wei Z, Liu J, Wang J. [Characteristics of out-of-hospital acute coronary heart disease deaths of Beijing permanent residents at the age of 25 or more from 2007 to 2009]. Zhonghua Xin Xue Guan Bing Za Zhi. 2012;40(3):199-203. [PMID]
22. Shao F, Li CS, Liang LR, Li D, Ma SK. Outcome of out-of-hospital cardiac arrests in Beijing, China. Resuscitation. 2014;85(11):1411-7. [DOI] [PMID]
23. Liu X, Li S. Improvement of treatment strategy for acute myocardial infarction by check pain center and regional synergy system. Chinese Circul J. 2018;33:830-2.
24. Zhao D, Liu J, Wang M, Zhang X, Zhou M. Epidemiology of cardiovascular disease in China: current features and implications. Nat Rev Cardiol. 2019;16(4):203-12. [DOI] [PMID]
25. Wang W, Liu Y, Liu J, Yin P, Wang L, Qi J, et al. Mortality and years of life lost of cardiovascular diseases in China, 2005-2020: Empirical evidence from national mortality surveillance system. Int J Cardiol. 2021;340:105-12. [DOI] [PMID]
26. Maniecka-Bryła I, Pikala M, Bryła M. Life years lost due to cardiovascular diseases. Kardiol Pol. 2013;71(10):1065-72. [DOI] [PMID]
27. Zhou M, Wang H, Zeng X, Yin P, Zhu J, Chen W, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2019;394(10204):1145-58. [DOI] [PMID]
28. Wang Y, Li X, Zhou M, Luo S, Liang J, Liddell CA, et al. Under-5 mortality in 2851 Chinese counties, 1996–2012: a subnational assessment of achieving MDG 4 goals in China. Lancet. 2016;387(10015):273-83. [DOI] [PMID]
29. Liu S, Li Y, Zeng X, Wang H, Yin P, Wang L, et al. Burden of Cardiovascular Diseases in China, 1990-2016: Findings From the 2016 Global Burden of Disease Study. JAMA Cardiol. 2019;4(4):342-352. [DOI] [PMID] [PMCID]
30. Song M, Hildesheim A, Shiels MS. Premature Years of Life Lost Due to Cancer in the United States in 2017. Cancer Epidemiol Biomarkers Prev. 202;29(12):2591-8. [DOI] [PMID] [PMCID]
31. Pham T-M, Fujino Y, Ide R, Tokui N, Kubo T, Mizoue T, et al. Years of life lost due to cancer in a cohort study in Japan. Eur J Public Health. 2009;19(2):189-92. [DOI] [PMID]
32. Pham TM, Fujino Y, Matsuda S, Yoshimura T. Premature mortality due to cancer in Japan, 1995 and 2005. Int J Cancer. 2010;127(1):190-4. [DOI] [PMID]
33. Brustugun OT, Møller B, Helland A. Years of life lost as a measure of cancer burden on a national level. Br J Cancer. 2014;111(5):1014-20. [DOI] [PMID] [PMCID]
34. Soneji S, Beltrán-Sánchez H, Sox HC. Assessing progress in reducing the burden of cancer mortality, 1985-2005. J Clin Oncol. 2014;32(5):444-8. [DOI] [PMID] [PMCID]
35. Heidari A, Kabir MJ, Khatirnamani Z, Gholami M. Mortality Rate and Years of Life Lost Due to Premature Death From Respiratory Diseases: A Five-year Trend (2014-2018). J Res Health. 2023;13(1):1-10. [DOI]
36. Zhou C-L, Lv L-S, Jin D-H, Xie Y-J, Ma W-J, Hu J-X, et al. Temperature Change between Neighboring Days Contributes to Years of Life Lost per Death from Respiratory Disease: A Multicounty Analysis in Central China. Int J Environ Res Public Health. 2022;19(10):5871. [DOI] [PMID] []
37. Torkashvand Moradabadi M, Abbasi M. An Epidemiological study of mortality among elderly in Iran using Years of Life Lost (YLL) index during 2011 to 2017. Payesh. 2020;19(1):85-97. [DOI]
38. Alavi SS, Naemi H, Hosseinzadeh A. Investigating the Frequency Distribution of Dying Elderly People in Sabzevar in Terms of Associated Risk Factors in Years 2011 to 2013. J Sabzevar Univ Med Sci. 2016;23(4):626-33. [Article]
39. Salamatbakhsh M, Mobaraki K, Sadeghimohammadi S, Ahmadzadeh J. The global burden of premature mortality due to the Middle East respiratory syndrome (MERS) using standard expected years of life lost, 2012 to 2019. BMC Public Health. 2019;19(1):1523. [DOI] [PMID] [PMCID]
40. GBD 2016 Brazil Collaborators. Burden of disease in Brazil, 1990-2016: a systematic subnational analysis for the Global Burden of Disease Study 2016. Lancet. 2018;392(10149):760-775. [DOI] [PMID]
41. Moura EC, Santos WD, Neves AC, Schwarz E, Gomes R. Mortality in Brazil according to gender perspective, years 2000 and 2010. Rev Bras Epidemiol. 2016;19(2):326-38. [DOI] [PMID]
42. Wang F, Wang W, Yin P, Liu Y, Liu J, Wang L, et al.Mortality and Years of Life Lost in Diabetes Mellitus and Its Subcategories in China and Its Provinces, 2005-2020. J Diabetes Res. 2022;2022:1609267. [DOI] [PMID] []
43. Gregg EW, Zhuo X, Cheng YJ, Albright AL, Narayan KM, Thompson TJ. Trends in lifetime risk and years of life lost due to diabetes in the USA, 1985-2011: a modelling study. Lancet Diabetes Endocrinol. 2014;2(11):867-74. [DOI] [PMID]
44. Weisman A, Fazli GS, Johns A, Booth GL. Evolving Trends in the Epidemiology, Risk Factors, and Prevention of Type 2 Diabetes: A Review. Can J Cardiol. 2018;34(5):552-64. [DOI] [PMID]
45. Schellenberg ES, Dryden DM, Vandermeer B, Ha C, Korownyk C. Lifestyle interventions for patients with and at risk for type 2 diabetes: a systematic review and meta-analysis. Ann Intern Med. 2013;159(8):543-51. [DOI] [PMID]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution 4.0 International License. |
